Stay updated on Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3 on the page, representing a small metadata update to the page.
    Difference
    0.0%
    Check dated 2026-07-04T13:27:16.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The study page was updated from revision v3.6.0 to v3.6.2, signaling a maintenance update to the page. It does not alter the study details, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-06-27T07:45:48.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now shows that recruitment is closed, indicating no new participants will be enrolled. This clarifies the study's current status for participants and investigators reviewing eligibility and enrollment options.
    Difference
    0.3%
    Check dated 2026-06-13T05:12:58.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, signaling a minor site update.
    Difference
    0.0%
    Check dated 2026-06-05T22:44:30.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a new site/template revision has been applied. This appears to be a minor metadata update rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-05-15T14:40:46.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3, indicating a site release rather than a change to the study’s content.
    Difference
    0.0%
    Check dated 2026-04-24T05:50:16.000Z thumbnail image

Stay in the know with updates to Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.